CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Phase 1 Trial for Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell("HYNR-CS-Allo Inj") Treatment in Amyotrophic Lateral Sclerosis(ALS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01758510
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:17.830175+00:00
Published At: 2019-05-16T00:00:00+00:00
Record Updated At: 2019-05-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Amyotrophic Lateral Sclerosis", "Motor Neuron Disease", "Neuromuscular Disease", "Neurodegenerative Disease", "Central Nervous System Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-05-16"
protocolSection.identificationModule.nctId: "NCT01758510"
protocolSection.identificationModule.officialTitle: "An Open-label, Phase 1 Trial for Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell(\"HYNR-CS-Allo Inj\") Treatment in Amyotrophic Lateral Sclerosis(ALS)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.